Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

Abbott gets FDA nod for updates to heart failure monitoring system

7 October 2026 · By · Wire by Fusion42

Published

7 October 2026

Topic

regulatory

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 11 October 2026 · Fusion42 review

Abbott received FDA approval for updates to its CardioMEMS heart failure monitoring system, allowing patients to view their pulmonary artery pressure readings directly on their phones, enhancing patient engagement in managing their care.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 5 Oct 2026 and 7 Oct 2026.

◆ ◆ The Wire takeaway

You can now build patient-facing interfaces around pulmonary pressure data without waiting for regulatory barriers to clear. This will accelerate adoption for digital health startups focused on remote cardiac care.

◆ Coverage

2 sources · first reported 5 Oct 2026 · latest 7 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfda-approvalheart-failuremedical-devicespatient-monitoringdigital-health